THE SPENDING bill that reopened the federal government this month included a small, but important provision: It closed the 2018 Farm Bill loophole that fueled the rise of hemp-derived intoxicating cannabinoids.
Under the bill signed Nov. 12, most consumable hemp THC products, including delta-8, delta-10, and many CBD products, will become federally illegal in 365 days. This will effectively put an end to some hemp farmers’ operations and businesses that manufacture the hemp-derived consumables, particularly in states that have not legalized cannabis for recreational use.
However, the law risks sweeping up non-intoxicating wellness products, the main selling-point of which is CBD, which is not intoxicating. Here’s a look at how this minor part of the budget bill will send shockwaves through the industry.
What started it all
The 2018 Farm Bill legalized commercial hemp but also allowed hemp-derived cannabinoids containing less than 0.3% delta-9 THC by dry weight to circulate nationwide. Manufacturers quickly learned how to convert CBD isolate into intoxicating forms of THC that technically complied with statute, and an unregulated marketplace exploded.
Convenience stores, gas stations, online storefronts, and wellness shops became de facto retailers of intoxicating THC products operating outside any testing, age-gating or packaging rules.
They have proliferated in states that have not legalized cannabis for recreational or medical use.
Industry effects.
Cannabis operators in legalized markets have cheered the new law and expect it will shift intoxicating hemp sales into state-licensed channels, reduce competition from gas-station THC, stabilize pricing and giving licensed operators a clearer playing field.
The following sectors will be hit:
Hemp product brands — Makers of intoxicating hemp-derived drinks, gummies, vapes and edibles face the potential for a full market collapse. Industry groups estimate more than 90% of existing CBD and hemp- derived THC products will exceed the new limit.
Hemp farmers — Those growing for cannabinoids, rather than fiber or grain, face the sharpest economic shock. Many entered the hemp market after 2018 expecting long- term demand for CBD and related extracts.
Nonintoxicating CBD brands — Even low-dose wellness products may not survive the 0.4 mg per-container limit. Many popular. tinctures, capsules, and topicals exceed that threshold, putting mainstream CBD products at risk despite not being intoxicating.
New rules for hemp-derived products
Starting November 2026, hemp-derived products are only federally legal if they meet the following requirements:
- Each container may no more than 0.4 milligrams of total THC.
- May not contain cannabinoids synthesized or manufactured outside the plant.
- May not include cannabinoids with similar effects to THC, as determined by federal health regulators.
- No intermediate hemp-derived cannabinoid products marketed directly to consumers
Provide a Thorough Response to OSHA Within Five Days
Takeaway
This law rewires the competitive landscape. For regulated cannabis operators, the next year offers an opportunity to reclaim market share and stabilize pricing in categories distorted by intoxicating hemp products.
For hemp producers and manufacturers, it is a countdown to either reinvention or shutdown, with a narrow path for survival unless Congress adopts a regulatory alternative.
The final outcome depends on whether industry coalitions can use the next 12 months to advance a replacement framework. What is clear now is that the era of unregulated intoxicating hemp, born from the 2018 Farm Bill loophole, is ending nationwide.